Atossa Genetics to Present at the 2013 Aegis Capital Healthcare Conference
September 24, 2013 10:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, Chief Financial Officer & General Counsel,...
Atossa Genetics to Conduct Free Webinar: How to Invest Ahead of Breast Cancer Awareness Month
September 23, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced that Dr. Steven C. Quay, Chairman, President & CEO, will...
Atossa Genetics Acquires Rights to Patents Covering a Novel Screening Test for Breast Cancer From the Dr. Susan Love Research Foundation
July 13, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jul 13, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics Completes $6.6 Million Over-Subscribed Private Placement
June 27, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jun 27, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics Announces Licensing of Its New National Reference Laboratory for Breast Health
May 24, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 24, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. and HLB, LLC Announce Partnership to Manufacture Atossa's Patented, FDA-Cleared MASCT System for Breast Cancer Risk Assessment
May 03, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA and CHICAGO, IL--(Marketwire - May 3, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular...
Atossa Genetics Appoints Tim Hunkapiller, Ph.D., to Its Scientific Advisory Board
April 14, 2011 11:28 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Apr 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Steven C. Quay, M.D., Ph.D., of Atossa Genetics Elected as a Fellow of the College of American Pathologists
March 14, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - March 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Seattle Business Magazine Recognizes Steven C. Quay, M.D., Ph.D., of Atossa Genetics, Inc., as One of the Pacific Northwest's Top Leaders in Health Care
March 04, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - March 4, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement
October 01, 2010 09:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...